A recent paper on the future of radiation oncology reports on the trend toward a greater role for shared decision making and patient-reported outcomes, such as the interrelated benchmarks of patient satisfaction, engagement, and treatment-plan adherence.
What is the best approach to learning more about the field of Radiation Oncology?
In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy were cancer-free 28 months after treatment. Side effects typical of standard radiation were also reduced in some cases.
An old idea of retreating lung tumors with radiation is new again, especially with the technological advances seen in radiation oncology over the last decade.
Many larger-chested women develop moist desquamation under their breasts and are treated with Domeboro solution and air exposure. Are there any better methods for treating this condition?
The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) have set forth several recommendations on radiation therapy after prostatectomy.
A breast cancer assay helped quantify the risk of recurrence after surgical excision for ductal carcinoma in situ (DCIS) without radiation.
How do certain chemotherapy agents make tumors more radiosensitive?
Patients with aggressive brain tumors can be effectively treated with smaller radiation fields to spare the rest of the brain and preserve cognition.
Persons with non-small cell lung cancer who received definitive radiotherapy survived longer when beta-blockers were added to the mix.
Proposed reductions in radiotherapy prompted a joint reaction from ASTRO and other cancer care organizations.
The American Society of Clinical Oncology has released a nearly 100-page report detailing the year's most significant developments in cancer.
A small study showed the safety of using gene therapy in the salivary gland to repair damage caused by radiation for head and neck cancer.
A new tumor-tracking technique delivers higher levels of radiation to moving tumors while sparing healthy tissue in lung cancer patients. This technique is moving closer to the clinic.
Spermatogonial stem cells were used to overcome male infertility, which could help prepubertal boys rendered infertile by cancer treatments.
Administering radiotherapy after prostatectomy helped nearly two-thirds of users in a recent study remain free of prostate cancer after 10 years.
This year-long study focused on the workflow of a Radiation Oncology department and found a strong correlation between implementing a Conditions Reporting System and increasingly positive responses to staff surveys that focused on the culture of safety within the department.
The risk of uterine cancer recurrence may be increased by waiting too long after a hysterectomy to begin radiation therapy. For patients with uterine cancer who are not receiving chemotherapy, tumors were found to be more likely to return if radiation therapy was delayed 9 weeks or longer following surgery.
When measures are implemented to ensure that radiation protocols are followed, deviations decrease and overall survival improves in patients with cancer.
The breast cancer treatment brachytherapy, heralded for its low complication rates, actually results in more complications than whole-breast radiation 1 year after treatment.
The ancient Chinese medical practice can relieve the symptoms of dry mouth in patients undergoing radiotherapy, according to the largest trial yet to investigate this effect. Radiotherapy for head and neck cancer often produces this unpleasant and distressing side effect because patients' salivary glands are damaged by radiotherapy.
Differences in the impact of aspirin in various forms of cancer are highlighted in two studies recently published in the oncology literature.
This week, the Advisor Forum answers a question about the use of amifostine (Ethyol, generic) as a radioprotectant.
Long-term follow-up results from two clinical trials have confirmed substantially longer survival for certain patients with anaplastic oligodendrogliomas if they are treated with a combination of chemotherapy and radiation therapy instead of radiation alone.
Researchers have identified 12 genetic markers linked with susceptibility for erectile dysfunction after radiotherapy for prostate cancer.
For children who undergo brain radiation therapy, permanent neurocognitive adverse effects are a significant risk. These risks arise because the radiation often encounters healthy tissue, which reduces the formation of new cells, particularly in the hippocampus.
Responses to radiation therapy are significantly different among patients with oropharyngeal cancer, depending on if they carry the human papillomavirus (HPV). More individualized radiation treatment regimens could result from these findings, according to a recent study.
A controlled fasting period lasting no more than 48 hours improved the effectiveness of chemotherapy and radiation therapy in mice with gliomas.
Lying face-down was associated with a reduced amount of irradiated lung and heart during breast cancer treatment compared with lying on the back.
Intermittent androgen deprivation was just as effective as continuous therapy in overall survival, and improved some quality-of-life factors.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Immunotherapy and the Future of Prostate Cancer Treatment
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|